Evidence map›Paper›PMID 38067256›Full record

ArticleCancers2023

Influence of C

Malwina Sosnowska, Marta Kutwin, Katarzyna Zawadzka, Michał Pruchniewski, Barbara Strojny, Zuzanna Bujalska, Mateusz Wierzbicki, Sławomir Jaworski, Ewa Sawosz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Malwina SosnowskaDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.
Marta KutwinDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.ORCID 0000-0001-7059-7875
Katarzyna ZawadzkaDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.
Michał PruchniewskiDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.
Barbara StrojnyDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.ORCID 0000-0002-2642-5491
Zuzanna BujalskaDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.
Mateusz WierzbickiDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.ORCID 0000-0003-3623-8929
Sławomir JaworskiDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.ORCID 0000-0002-4619-941X
Ewa SawoszDepartment of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.
Warsaw University of Life Sciences · PL

Funding

National Science Centre Poland 2019/33/N/NZ7/01392
6 · The paper itself

Abstract

The epithelial-mesenchymal transition (EMT) is a process in which epithelial cells acquire the ability to actively migrate via a change to the mesenchymal phenotype. This mechanism occurs in an environment rich in cytokines and reactive oxygen species but poor in nutrients. The aim of this study was to demonstrate that the use of a fullerene C

Indexed as

autophagyfullereneinflammationinvasionliver canceroxidative stressphenotype transition

Identifiers

PMID38067256
PMCPMC10705132
OpenAlexW4388945496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.